What is tumor-infiltrating lymphocyte (TIL) therapy? | MD Anderson Cancer Center

Tumor-infiltrating lymphocytes (TILs) are a type of experimental cell therapy being developed for a variety of solid tumors, including melanoma and cervical cancer. Jason Bock, Ph.D., explains TIL therapy and their early promise as a new immunotherapy approach.

What is tumor-infiltrating lymphocyte (TIL) therapy? | UT MD Anderson Cancerwise Blog 2021 04 TIL therapy: 6 things to know Top Jump To: Back --> Back TIL therapy: 6 things to know BY Clayton Boldt, Ph.D. | Close Share this article Via social media: Or copy the link: Copy to clipboard Copy April 15, 2021 Medically Reviewed  |  Last reviewed by a UT MD Anderson medical professional on April 15, 2021 Adoptive cellular therapy is a form of immunotherapy that uses cells from our immune systems, such as T cells, as a treatment for cancer. The immune cells are usually isolated from a patie

related reading

• Immunotherapy for Cancer - NCIcancer.gov
• 癌症治療的海豹特種部隊 淺談CAR-T細胞治療法::台灣癌症基金會canceraway.org.tw
• Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designationmed.stanford.edu
• Medicine's Endgamenotboring.co
• Cancer cells educate natural killer cells to a metastasis-promoting cell state - PMCpmc.ncbi.nlm.nih.gov
• Understanding Cell + Gene Therapypatienteducation.asgct.org
• Targeting telomerase for cancer therapy | Oncogenenature.com
• Frontiers | Therapeutic Antibodies against Intracellular Tumor Antigensfrontiersin.org
• Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
• Teaching an old dog new tricks: next-generation CAR T cells | British Journal of Cancernature.com
• The blood cancer that became solvableworksinprogress.news
• Cancer cells educate natural killer cells to a metastasis-promoting cell state - PubMedpubmed.ncbi.nlm.nih.gov